eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | melanoma, malignant |
| Comorbidity | C0037274|skin disease |
| Sentences | 2 |
| PubMedID- 22397594 | Ipilimumab, marketed as yervoy® by bristol-myers squibb, is the first therapeutic agent which increases survival time in patients with metastatic malignant melanoma, the leading cause of death from skin disease [89]. |
| PubMedID- 19898857 | Epidemiological, clinical and laboratory studies have implicated solar ultraviolet (uv) radiation in various skin diseases including, premature aging of the skin and melanoma and non-melanoma skin cancers. |
Page: 1